Helsinki University
Lahti, Kanta-Häme, 15140, Finland
NCT Number: NCT03997175
Children were exposed to biodiverse material or non-diverse material in sand pits. The two arms were compared. Immune response and bacterial markers were followed.
Looking for future studies?
Notify Me3 year–5 year
All sexes
Interventional
Not applicable
Lahti, Kanta-Häme, 15140, Finland
Children of age 3-5 were randomly divided into two groups (arms). One received guidance and biodiverse material for 20 minutes each day for two weeks. The other received the a similar material and guidance but the microbial community in the material was poor in diversity. Bacterial community changes and immune system markers were analyzed and compared between the two arms. Potential changes in Interleukin 10 was the primary outcome.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biodiversity sand contained biodiversity powder that contains a highly diverse and rich microbial community but no known pathogens.
Other names: Biodiversity sand, Biodiversity intervention
Sand that looks like intervention sand but does not have high biodiversity
Other names: Placebo sand
Time frame: two weeks
The difference between day 0 and a follow up day in intervention
Time frame: two weeks
all potential changes in bacterial profile are measured on skin and stool samples
Time frame: two weeks
all measured changes in interleukin 17 levels
Time frame: two weeks
change in tgf-beta levels
Time frame: two weeks
potential changes in the ratio of these two citokines
Time frame: four weeks
potential changes that last for four weeks
University of Helsinki
Other
ImmunoGarden - Effect of Modified Playground Environment on Health, Particularly Immune System
Acronym: ImmunoG1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03409367
Atopic Dermatitis, Atopic Disorders
Denver, Colorado, United States
View Trial DetailsNCT04397081
Asthma, Atopic Asthma
Adana, Merkez, Turkey (Türkiye)
View Trial DetailsNCT03050151
Atopic Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial DetailsNCT05334940
Atopic Disorders
Berlin, Germany
View Trial Details